In conclusion, the use of the serum MIC-1 and serum CA19-9 levels is effective for screening biliary tract cancer, and the biliary MIC-1 level is more effective for diagnosing early biliary tract cancer than conventional serum tumour markers and biliary cytology. This evidence concerns the gene GDF15 and biliary tract neoplasm.